Speech-Language Pathologists in Shelbyville, IN Accepting Medicare

3 Speech-Language Pathologists found. Showing 1 - 3

Mrs. Jacqueline Bryant Davis Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3572 N Tanglewood Ln, Shelbyville, IN 46176 Phone: 317-398-4447

Lydia Hittle, MA CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1238 Oak Ln, Shelbyville, IN 46176 Phone: 317-512-5364

Frances Leslie Stephen Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2216 N Riley Hwy, Shelbyville, IN 46176 Phone: 831-739-2337

News Archive

Jersey Shore opens new CVICU to provide post-operative care for cardiac surgery patients

Jersey Shore University Medical Center recently unveiled the new CardioVascular Intensive Care Unit (CVICU) - a twelve bed critical care unit providing post-operative care for cardiac surgery patients, including those who receive traditional open heart surgery and newer, complex interventional cardiovascular procedures.

Primary prevention of coronary heart disease: challenges and achievements

The European Society of Cardiology together with other partner Societies has engaged in a comprehensive programme of prevention of cardiovascular disease (CVD) since 1994. Guidelines on this important topic have been developed and updated at regular intervals over the last 13 years, most recently in 2007.

'Pay for performance' programs focus on high quality care delivery

Paying doctors for how they perform specific medical procedures and examinations yields better health outcomes than the traditional "fee for service" model, where everyone gets paid a set amount regardless of quality or patient outcomes, according to new research conducted by UC San Francisco and the New York City Department of Health and Mental Hygiene.

Data from Phase 1 and Phase 2a studies of inhaled liposomal ciprofloxacin to be presented at ERS Congress

Aradigm Corporation (OTCBB: ARDM) ("Aradigm") today announced it is presenting data from its Phase 1 and Phase 2a studies at the ERS Annual Congress in Vienna, Austria, September 12-16, 2009.

Read more Medical News

› Verified 3 days ago